Nicholas Kamp
Cardiovascular Disease · Indianapolis, INNPI 1417489923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Abbott at 34.7% of the total. That places this record below the midpoint for cardiovascular disease clinicians in IN, where the typical reported total is $2,452.
Across 68 payments — averaging $49.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$582
- Edwards Lifesciences$455
- Cardiovascular Systems Inc.$276
- Boston Scientific$187
- Shockwave Medical, Inc$156
- plus $545 from 15 others
Across 53 payments — averaging $1961.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$104K
What the payments were for
- Food & beverage$3,13193%
- Education$2387%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $1,167 |
| Medtronic | 6 | $582 |
| Edwards Lifesciences | 7 | $455 |
| Cardiovascular Systems Inc. | 3 | $276 |
| Boston Scientific | 8 | $187 |
| Shockwave Medical, Inc | 1 | $156 |
| Novo Nordisk | 4 | $93 |
| Biotronik Inc. | 3 | $69 |
| Cardiva Medical, Inc. | 3 | $64 |
| Bayer | 3 | $61 |
| Stryker | 1 | $49 |
| Philips North America LLC | 1 | $32 |
| Novartis | 2 | $30 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $27 |
| Recor Medical Inc | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Livanova USA, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Terumo Medical Corporation | 1 | $15 |
| Chiesi USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,368 in reported general payments places this provider in the 50th percentile of 408 cardiovascular disease providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 144 | $817 |
| Atorvastatin Calcium | 29 | $117 |
| Cephalexin | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Indianapolis
- John MillerIndianapolis$354K
- David KovacichIndianapolis$327K
- Vijay RaoIndianapolis$247K
- Atul ChughIndianapolis$242K
- James TrippiIndianapolis$239K
- Christopher HealyIndianapolis$209K
- Richard KovacsIndianapolis$136K
- George LolayIndianapolis$128K
- Onyedika IlonzeIndianapolis$125K
- Noel DasguptaIndianapolis$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.